Vical, Inc.

VICL NASDAQ
0.8500
+0.0200
+2.41%
已收盘, 16:00 06/24 EDT
开盘
0.8375
昨收
0.8300
最高
0.8760
最低
0.8375
成交量
25.89万
成交均量(3M)
21.56万
52周最高
1.470
52周最低
0.7700
换手率
1.13%
市值
1,939.93万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Vical, Inc. VICL股票价格,Vical, Inc.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including Phase III clinical trial of ASP0113 for prevention of cytomegalovirus (CMV) reactivation in stem cell transplant recipients and Phase II clinical trial of ASP0113 for prevention of CMV infection in kidney transplant recipients; Phase I/II clinical trial of its therapeutic genital herpes vaccine, designed to reduce viral shedding and genital herpes lesions in herpes simplex virus type 2 (HSV-2) infected patients; an ongoing Phase I program of VL-2397 for invasive fungal infections, and completed preclinical program, with an allowed investigational new drug application (IND) using its CyMVectin prophylactic vaccine formulated with its Vaxfectin adjuvant.
展开 >

最近浏览

名称
价格
涨跌幅